Wehave previously shown that high altitude pulmonary edema-susceptible subjects (HAPE-S) have an accentuated pulmonary vascular response to hypoxia. In this study, we investigated the relationship between plasma endothelin-1 (ET-1) levels and the acute hypoxic pulmonary vascular response in HAPE-Sand control subjects. In six HAPE-Sand seven healthy subjects, we evaluated acceleration time/right ventricular ejection time (AcT/RVET)using Doppler echocardiography, and measured plasma ET-1 levels by radioimmunoassay (RIA) before and after 5 minutes of breathing 10% oxygen. The HAPE-S showed a significantly increased pulmonary vascular response to hypoxia compared with healthy subjects. However, no statistically significant changes of plasma ET-1 levels were observed before and after hypoxia in both groups. Weconclude that the increased pulmonary vascular response to acute hypoxia in HAPE-Smay not be related to ET-1 release. (Internal Medicine 35: 257-260, 1996) 
Introduction
Pulmonaryhypertension is one of the clinical characteristics of high altitude pulmonary edema (HAPE). We have previously shown that HAPE-susceptible subjects (HAPE-S) have an accentuated pulmonary vascular response to hypoxia compared to normal subjects, suggesting that they have a constitutional abnormality in adaptation to high altitude ( 1 ) . Endothelin (ET) is one of several vasoactive agents, which has been knownto be a possible mediator of hypoxic pulmonary vasoconstriction in humanand animal experiments (2) (3) (4) . Recently, we treated a patient of HAPEwith pulmonary hypertension, in which an increased plasma level of ET-1 was noted on admission. We speculated that ET-1 release was the causative factor in the development of pulmonary hypertension and/or abnormal pulmonaryvascular response to hypoxia in HAPE.
As previously shown, pulsed Doppler echocardiography is a useful method to evaluate pulmonary artery pressure noninvasively (5) . In the present study, we investigated the difference in pulmonary vascular response to acute hypoxia between HAPE-S and control subjects by using pulsed Doppler echocardiography, and we also measured the plasma ET-1 levels before and after hypoxic exposure, in order to evaluate the role of ET-1 in the acute hypoxic pulmonary vascular response in HAPE-S.
Methods

Subjects
We studied six HAPE-Sand seven control subjects. All subjects were Japanese nonsmokers and low-altitude inhabitants. Before the study, they underwent physical examinations, routine laboratory tests, chest roentgenograms, electrocardiograms and pulmonary function tests. All had mountain climbing experience, but none was exposed to altitudes above 2,000 meters (m) for the four week period before the study. All subjects have informed consent and the study protocol was approved by the Institutional Committee on HumanResearch Studies under hypoxia The subjects breathed from a reservoir tank containing a hypoxic gas mixture of 10%oxygen in nitrogen through a tightfitting face mask, in which two one-way flap valves were placed to prevent rebreathing and contamination by room air. Before and 5 minutes after the hypoxic breathing, an echocardiogram, including M-mode, two-dimensional, and Doppler echocardiogram, was performed. The oxygen saturation (SaO2) was monitored by pulse oximeter (PULSOX-SP, Japan).
Evaluation of pulmonary vascular response to hypoxia An ultrasound system (PH SONOS1500) equipped with 2.0/2.5 MHztransducers was used for either pulsed Doppler modeor continuous-wave Doppler mode. Pulmonary flow indexes included acceleration tim (AcT), right ventricular ejection time (RVET), and the calculated ratio of AcT/RVET.The Doppler sample volume area was located just proximal to the pulmonary valve in the center of the right ventricular outflow tract, without any angle correction. The recordings were first assessed for a systolic velocity curve pattern according to Kitabatake et al (7) . The technique of securing the spectral signal of tricuspid regurgitation has been described (8) . Systematic search for the Doppler signal of tricuspid regurgitation was performed to achieve optimal recordings of the spectral display. The pulmonary artery systolic pressure was calculated 
Measurement of ET-1
Plasma levels of ET-1 were analyzed before and after hypoxia. Blood samples for analysis ofET-1 were drawn from the cubital vein and put into ice-chilled tubes containing K2EDTA. Plasma was immediately separated by centrifugation at 4°C within 10 minutes. Plasma samples were stored at -30°C until assayed. We measured plasma ET-1 level by radioimmunoassay (RIA), as previously described (9 
Results
Anthropometric data and results of pulmonary function tests are summarized in Table 1 . Except for the total lung capacity (TLG) and carbon monoxide diffusing capacity (DL^o), the differences between the two groups werenot statistically significant in any of these parameters. For all subjects, heart rate (HR) increased and SaC>2 decreased after hypoxic exposure ( Table 2 ). There were no significant differences in these changes between the HAPE-Sgroup and the control group. Doppler echocardiogram data and plasma ET-1 levels are shown in Table 2 . All of the patients had good quality pulsed wave Doppler tracings from the right ventricular outflow tract. There was no significant difference in AcT/RVETbetween the two groups before hypoxia, but AcT/RVETduring hypoxia in HAPE-Swas significantly lower than that of the control group In the control group, tricuspid regurgitation signals were detected in only two subjects before hypoxia and in three subjects during hypoxia. The plasma levels ofET-1 are also presented in Table 2 . No significant differences in ET-1 levels were observed between the two groups before hypoxia. Plasma level of ET-1 did not change after the hypoxic period in both groups. There was no Endothelin-1 in HAPE-S Table 2 . Doppler Echocardiographic and Endothelin-1 Data AcT: acceleration time, RVET:right ventricular ejection time, ET-1 : endothelin-1, HR: heart rate, Tr: tricuspid regurgitation, SaC^: saturation, R.A.: room air, 10%: 10% oxygen, *: p<0.05 from room air, #: p<0.05 between the two groups.
significant difference in plasma ET-1 during hypoxic exposure betweenthe two groups.
Discussion
This study was conducted to investigate the relationship between the plasma ET-1 level and the early acute hypoxic pulmonary vascular response. Wefound a small but significant difference in AcT/RVETafter hypoxic exposure between HAPE-S and control subjects, which was consistent with our previous results (1 , 5) . Wepreviously evaluated the pulmonary vascular response to hypoxia in HAPE-Sby using right heart catheterization and echocardiogram, and found that AcT/RVETwas a good index to evaluate the pulmonary artery pressure (1, 5) . According to Tramarin et al (10) and Chan et al (1 1), tricuspid regurgitation velocity obtained by echocardiogram demonstrates the highest correlation with meanpulmonary artery pressure (r=0.72). They also suggested that the tricuspid regurgitation velocity and pulmonary flow index (AcT/RVET) should be used concomitantly in the same patient in order to increase the precision in predicting pulmonary artery pressure. In the present study, however, the Doppler-detectable tricuspid regurgitation signals were so limited that it was impossible to use the tricuspid regurgitation velocity together with AcT/RVETto increase the precision (Table 2) . Color-coded two-dimensional Doppler as sistance mayimprove the identification of regurgitant jets suitable for assessing tricuspid pulmonary gradients (10) .
Even so, we found a significant difference in AcT/RVET after hypoxic exposure in HAPE-S, suggesting that HAPE-Shad an abnormal pulmonary vascular response to hypoxia.
Although the values of AcT/RVETwere variable in each subject after 5 minutes of 10% oxygen breathing, we found that the plasma ET-1 levels did not change during the hypoxic period in both groups. These data suggest that the acute hypoxic pulmonaryvascular response was not conducted with ET-1 release. Furthermore, our data indicated that the accentuated pulmonary vascular response to acute hypoxia in HAPE-Swas not involved in the enhancedrelease ofET-1. Itis likely that ETtaken into consideration that, although acute hypoxia stimulated the release and/or extraction ofET-1 in the lung tissue, the plasma concentration ofET-1 was not affected in spite of these alterations in the lung. A recent study by Li et al (14) demonstrated that ET-1 and ETreceptor gene expression was enhanced by chronic hypoxia, suggesting that chronic hypoxia may be an important stimulus for secretion of ET-1 from endothelial cells. So the role ofET-1 in the hypoxic pulmonary vasoconstriction is still controversial. Further studies are needed to elucidate the mechanismof the ET-1effect in the hypoxic pulmonaryvascular response. In summary,we demonstrated that the accentuated acute hypoxic pulmonary vascular response in HAPE-Swas not related to plasma ET-1 elevation. Therefore, the precise mechanism of the accentuated pulmonary vascular response to hypoxia in HAPE-Sremains unknown. Also, it is uncertain whether hormonal release contributes to the pulmonary response to hypoxia in HAPE-S. Further studies are needed to explain the precise mechanismof pulmonary hypertension in HAPE.
